Whistleblower Complaint Says Facebook Aware of Illegal Drug Activity

A consortium of Facebook insiders and critics filed a confidential whistleblower’s complaint to the Securities and Exchange Commission, claiming the social media giant is aware of illegal activity on its platform, such as the sale of opioids, and has failed to properly police it. The complaint, which was obtained by The Washington Post, includes dozens of pages of screenshots of opioids and other drugs for sale on Facebook and its photo-sharing site Instagram, with some having seemingly obvious tags such as “#buydrugsonline.”